KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
WTO TRIPS Council: Submission of South Africa on R&D Costs and Pricing of Medicines and Health Technologies
On Friday, 4 October 2019, the World Trade Organization (WTO) published a submission by the Republic of South Africa on “R&D Costs and Pricing of Medicines and Health Technologies” (IP/C/W/659). In this paper, South Africa requested the WTO TRIPS Council… Continue Reading
WIPO General Assembly 2019: KEI statement on the Report on the SCP
On Thursday, 3 October 2019, Knowledge Ecology International delivered the following statement on Agenda item 16, Report on the SCP. As part of the WIPO Secretariat’s review of existing research on patents and access to medical products and health technologies,… Continue Reading
WIPO General Assembly 2019: KEI statement on the Report on the SCCR
On Wednesday, 2 October 2019, Knowledge Ecology International delivered the following statement on Agenda item 15, Report on the SCCR. WIPO General Assembly Agenda item 15, Report on the SCCR Statement of Knowledge Ecology International With respect to the broadcasters… Continue Reading
WIPO General Assembly 2019: Opening statement of Knowledge Ecology International
On Tuesday, 1 October 2019, Knowledge Ecology International delivered the following opening statement at the 2019 WIPO General Assembly. Thank you Chair. KEI opposes any further work at the SCCR on a broadcast treaty, given the confusion over the objectives… Continue Reading
KEI letter to Senator Coons regarding injunction provisions in STRONGER Patents Act
KEI-Sen-Coons-injunctions-strongpatentsact-11Sept2019 September 11, 2019 The Honorable Senator Christopher Coons 218 Russell Senate Office Building Washington, DC 20510 Dear Senator Coons: Knowledge Ecology International (KEI) is a public interest group based in Washington, DC. KEI focuses on policies relating to the… Continue Reading
SCP 31: Upcoming WIPO review of existing research on patents and access to medical products and health technologies
As part of the work program of the Standing Committee on the Law of Patents (SCP), the secretariat of the World Intellectual Property Organization (WIPO) has been mandated to prepare a 40-50 page review of “existing research on patents and… Continue Reading
Transparency and delinkage embedded into the Human Rights Council’s agenda on access to medicines
On Thursday, 11 July 2019, the 41st session of the Human Rights Council (HRC) adopted, without a vote, resolution A/HRC/41/L.13, “Access to medicines and vaccines in the context of the right of the highest attainable standard of physical and mental… Continue Reading
Delinkage, TRIPS flexibilities, and alternative incentive frameworks emerge as flashpoints during Human Rights Council’s discussions on Access to Medicines and Vaccines
UPDATE: On 4 July 2019, the Core Group will submit a “TABLING REV 1” version of their resolution on “Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard… Continue Reading
Human Rights Council (2019): Core Group circulates zero draft on access to medicines and vaccines
At the 41st session (24 June 2019 – 12 July 2019) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, China, Egypt, Indonesia, India, Senegal, South Africa and Thailand) have circulated a resolution… Continue Reading
SCP 30: General statement of Knowledge Ecology International
On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, United Kingdom of Great Britain… Continue Reading